Centiva Capital, LP - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 55 filers reported holding PHOENIX BIOTECH ACQUISITION in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Centiva Capital, LP ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q4 2022$5,577,348
+1212.3%
541,490
+1187.9%
0.08%
+887.5%
Q3 2022$425,000
+0.7%
42,0460.0%0.01%
-20.0%
Q2 2022$422,00042,0460.01%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q2 2022
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,103$1,178,3230.31%
METEORA CAPITAL, LLC 152,060$1,657,4540.30%
Mint Tower Capital Management B.V. 141,089$1,5380.15%
BERKLEY W R CORP 96,777$1,054,8690.06%
Shaolin Capital Management LLC 108,877$1,1870.04%
AQR Arbitrage LLC 79,873$862,6280.04%
FNY Investment Advisers, LLC 2,084$220.03%
Polar Asset Management Partners Inc. 120,000$1,288,8000.02%
CLEAR STREET LLC 191,100$2,0830.02%
Walleye Capital LLC 47,936$522,5020.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders